Literature DB >> 32366588

OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in Francisella tularensis LVS.

Stuart Cantlay1, Kristen Haggerty1, Joseph Horzempa2.   

Abstract

Francisella tularensis is an intracellular pathogen and the causative agent of tularemia. The F. tularensis type six secretion system (T6SS) is required for a number of host-pathogen interactions, including phagolysosomal escape and invasion of erythrocytes. One known effector of the T6SS, OpiA, has recently been shown to be a phosphatidylinositol-3 kinase. To investigate the role of OpiA in erythrocyte invasion, we constructed an opiA-null mutant in the live vaccine strain, F. tularensis LVS. OpiA was not required for erythrocyte invasion; however, deletion of opiA affected growth of F. tularensis LVS in broth cultures in a medium-dependent manner. We also found that opiA influenced cell size, gentamicin sensitivity, bacterial viability, and the lipid content of F. tularensis A fluorescently tagged OpiA (OpiA-emerald-green fluorescent protein [EmGFP]) accumulated at the cell poles of F. tularensis, which is consistent with the location of the T6SS. However, OpiA-EmGFP also exhibited a highly dynamic localization, and this fusion protein was detected in erythrocytes and THP-1 cells in vitro, further supporting that OpiA is secreted. Similar to previous reports with F. novicida, our data demonstrated that opiA had a minimal effect on intracellular replication of F. tularensis in host immune cells in vitro However, THP-1 cells infected with the opiA mutant produced modestly (but significantly) higher levels of the proinflammatory cytokine tumor necrosis factor alpha compared to these host cells infected with wild-type bacteria. We conclude that, in addition to its role in host-pathogen interactions, our results reveal that the function of opiA is central to the biology of F. tularensis bacteria.IMPORTANCE F. tularensis is a pathogenic intracellular pathogen that is of importance for public health and strategic defense. This study characterizes the opiA gene of F. tularensis LVS, an attenuated strain that has been used as a live vaccine but that also shares significant genetic similarity to related Francisella strains that cause human disease. The data presented here provide the first evidence of a T6SS effector protein that affects the physiology of F. tularensis, namely, the growth, cell size, viability, and aminoglycoside resistance of F. tularensis LVS. This study also adds insight into our understanding of OpiA as a determinant of virulence. Finally, the fluorescence fusion constructs presented here will be useful tools for dissecting the role of OpiA in infection.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Francisella tularensis; OpiA; T6SS; antibiotic resistance; cell growth; cell viability; effector; microbial physiology; subcellular localization; virulence determinant

Year:  2020        PMID: 32366588      PMCID: PMC7317039          DOI: 10.1128/JB.00048-20

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  92 in total

1.  Cultivation of Bacterium tularense in Simplified Liquid Media.

Authors:  J T Tamura; I W Gibby
Journal:  J Bacteriol       Date:  1943-04       Impact factor: 3.490

Review 2.  Relationship between the Viable but Nonculturable State and Antibiotic Persister Cells.

Authors:  Mesrop Ayrapetyan; Tiffany Williams; James D Oliver
Journal:  J Bacteriol       Date:  2018-09-24       Impact factor: 3.490

3.  Invasion of erythrocytes by Francisella tularensis.

Authors:  Joseph Horzempa; Dawn M O'Dee; Donna Beer Stolz; Jonathan M Franks; Doris Clay; Gerard J Nau
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

4.  Construction and characterization of a highly efficient Francisella shuttle plasmid.

Authors:  Tamara M Maier; Andrea Havig; Monika Casey; Francis E Nano; Dara W Frank; Thomas C Zahrt
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

5.  Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.

Authors:  Joshua D Hall; Matthew D Woolard; Bronwyn M Gunn; Robin R Craven; Sharon Taft-Benz; Jeffrey A Frelinger; Thomas H Kawula
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

6.  Francisella tularensis invasion of lung epithelial cells.

Authors:  Robin R Craven; Joshua D Hall; James R Fuller; Sharon Taft-Benz; Thomas H Kawula
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

7.  High and novel genetic diversity of Francisella tularensis in Germany and indication of environmental persistence.

Authors:  C Schulze; K Heuner; K Myrtennäs; E Karlsson; D Jacob; P Kutzer; K GROßE; M Forsman; R Grunow
Journal:  Epidemiol Infect       Date:  2016-06-30       Impact factor: 4.434

8.  The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth.

Authors:  Olle M de Bruin; Jagjit S Ludu; Francis E Nano
Journal:  BMC Microbiol       Date:  2007-01-17       Impact factor: 3.605

9.  Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2.

Authors:  Aiping Qin; Barbara J Mann
Journal:  BMC Microbiol       Date:  2006-07-31       Impact factor: 3.605

10.  A Phosphatidylinositol 3-Kinase Effector Alters Phagosomal Maturation to Promote Intracellular Growth of Francisella.

Authors:  Hannah E Ledvina; Katherine A Kelly; Aria Eshraghi; Rachael L Plemel; S Brook Peterson; Brian Lee; Shaun Steele; Marlen Adler; Thomas H Kawula; Alexey J Merz; Shawn J Skerrett; Jean Celli; Joseph D Mougous
Journal:  Cell Host Microbe       Date:  2018-07-26       Impact factor: 21.023

View more
  2 in total

1.  PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by Francisella tularensis LVS.

Authors:  Stuart Cantlay; Christian Kaftanic; Joseph Horzempa
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

Review 2.  An Overview of Anti-Eukaryotic T6SS Effectors.

Authors:  Julia Monjarás Feria; Miguel A Valvano
Journal:  Front Cell Infect Microbiol       Date:  2020-10-19       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.